Screener
Harmony Biosciences Holdings, Inc. HRMY Q1 2026 earnings
Reported May 7, 2026 · Before market open
Revenue$215.4MMiss by $5.5M
EPS$0.55Miss by $0.21
Revenue estimate$220.8M
EPS estimate$0.76
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$274.5M
EPS estimate$1.11
Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harmony Biosciences Holdings, Inc. report Q1 2026 earnings?
- Harmony Biosciences Holdings, Inc. (HRMY) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Harmony Biosciences Holdings, Inc.'s Q1 2026 revenue and EPS?
- Harmony Biosciences Holdings, Inc. reported revenue of $215.4M and eps of $0.55 for Q1 2026.
- Did Harmony Biosciences Holdings, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $220.8M by $5.5M. EPS missed the consensus estimate of $0.76 by $0.21.
- How did Harmony Biosciences Holdings, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 16.6% from $184.7M a year earlier and eps declined 29.5% from $0.78.
- Where can I find Harmony Biosciences Holdings, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-056786) and the 10-Q periodic report (0001104659-26-056720) directly on SEC EDGAR. The filing index links above go to sec.gov.
